Malley Thomas's Form 4 filing
Kiniksa Pharmaceuticals International, plc (KNSA) · filed Aug 14, 2025
- Accession no.
- 0001415889-25-021941
- Filed
- Aug 14, 2025
- Trade date
- Aug 12-14, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 10 non-derivative transactions and 7 derivative transactions. Open-market sales total $5.86M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Malley ThomasCIK 0001403322 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +21,959 | $1.86 | +$40,843.74 | 34,505 | Direct | |
| Aug 12, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +27,448 | $3.80 | +$104,302.4 | 61,953 | Direct | |
| Aug 12, 2025 | Class A Ordinary Shares | SSaleDisposed | −49,407 | $32.40 | −$1,600,786.8 | 12,546 | Direct | |
| Aug 13, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +20,129 | $10.36 | +$208,536.44 | 32,675 | Direct | |
| Aug 13, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +30,000 | $9.88 | +$296,400 | 62,675 | Direct | |
| Aug 13, 2025 | Class A Ordinary Shares | SSaleDisposed | −50,129 | $33.32 | −$1,670,298.28 | 12,546 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +18,760 | $15.47 | +$290,217.2 | 31,306 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +33,237 | $14.33 | +$476,286.21 | 64,543 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseAcquired | +26,236 | $15.19 | +$398,524.84 | 90,779 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | SSaleDisposed | −78,233 | $33.09 | −$2,588,729.97 | 12,546 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −21,959 | $0.00 | $0 | 0 | Direct | |
| Aug 12, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −27,448 | $0.00 | $0 | 0 | Direct | |
| Aug 13, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −20,129 | $0.00 | $0 | 0 | Direct | |
| Aug 13, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −30,000 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −18,760 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −33,237 | $0.00 | $0 | 0 | Direct | |
| Aug 14, 2025 | Class A Ordinary Shares | MOption exerciseDisposed | −26,236 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.